Aileron Therapeutics: Board Shake-Up and Nasdaq Compliance Success
Company Announcements

Aileron Therapeutics: Board Shake-Up and Nasdaq Compliance Success

Aileron Therapeutics Inc (ALRN) just unveiled an update.

Nolan Sigal, M.D., Ph.D., has abruptly stepped down from his roles on Aileron Therapeutics’ Board of Directors and its Nominating and Corporate Governance Committee, with no conflicts cited as the cause. In a positive turn, the company has also been notified by the Nasdaq Stock Market that it’s back in compliance with listing requirements, ensuring its continued presence on the Nasdaq Capital Market.

Learn more about ALRN stock on TipRanks’ Stock Analysis page.

Related Articles
Ryan AdistIs ALRN a Buy, Before Earnings?
TheFlyAileron Therapeutics’ ALRN-6924 to be acquired by Advancium Health Network
TheFlyAileron completes enrollment of Cohort 2 of Phase 1b trial of LTI-03
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App